


Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Heplisav b | Hepatitis b virus hbsag surface protein antigen | 2021-02-18 | — | |
| Heplisav-b | Hepatitis b virus hbsag surface protein antigen | 2017-11-09 | — |
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|